Regulatory News
Monday, January 30, 2017
BRIEF-Motif Bio says Phase 3 clinical trial finishes patient treatment phase
* Motif Bio Phase 3 clinical trial finishes patient
treatment phase
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment